Komori
Synclayer (1724) · RiskRestated

Allocation of Costs Associated with Patent Ownership and Compensation

First written in FY2016. 14 of 16 entries say "Restated". Latest entry: FY2026-H1.

16entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2024-H12016: 120162017: 020172018: 220182019: 320192020: 020202021: 320212022: 120222023: 120232024: 220242025: 220252026: 12026
Same theme, other companies
Risk of costs associated with patent ownership and inventor compensationA theme 8 companies write about · 8 as a headwind · 0 as a tailwind

6 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「During the interim consolidated accounting period, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    特許の帰属・報酬に伴う費用負担リスクについて、重要な変更がないとされた。
  2. FY2025-H1RestatedAnnual report

    「During the interim consolidated accounting period, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    特許の帰属・報酬に伴う費用負担リスクについて、重要な変更がないとされた。
  3. FY2024WorsenedAnnual report

    「なお、当社は前述の部門以外の、例えばＳＥ部門、営業部門および製造部門でも技術者が在籍していることから、発明が行われる可能性があります。」

    特許の帰属・報酬に伴う費用負担リスクについて、従来の技術部門等に加え、SE部門、営業部門、製造部門でも発明が生じ得ることが明示され、対象範囲が広がった。
  4. FY2024-H1RestatedAnnual report

    「During the interim consolidated accounting period, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    特許の帰属・報酬に伴う費用負担リスクについて、重要な変更がないとされた。
  5. FY2024-Q1RestatedAnnual report

    「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」

    特許の帰属・報酬に伴う費用負担リスクについて、重要な変更がないとされた。
  6. FY2023-Q3RestatedAnnual report

    「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」

    特許の帰属・報酬に伴う費用負担リスクについて、重要な変更がないとされた。
  7. FY2022-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    特許の帰属・報酬に伴う費用負担リスクについて、重要な変更がないとされた。
  8. FY2021-Q3RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the third quarter. In addition, there were no material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」

    特許の帰属・報酬に伴う費用負担リスクについて、重要な変更がないとされた。
  9. FY2021-Q1RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the first quarter. In addition, there were no material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」

    特許の帰属・報酬に伴う費用負担リスクについて、重要な変更がないとされた。
  10. FY2020RestatedAnnual report

    「当社グループでは、技術部門において新製品および新技術の研究開発を行っており、社員が成した発明に対する特許の帰属は社内規程に基づいて対応しております。」

    社内規程および共同開発時の契約による特許帰属・費用管理を示しつつ、特許報酬・賠償等の費用負担リスクが継続している。
  11. FY2019-Q3RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the third quarter. In addition, there were no material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」

    特許の帰属・報酬に伴う費用負担リスクについて、重要な変更がないとされた。
  12. FY2019-Q2RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the second quarter. In addition, there were no material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」

    特許の帰属・報酬に伴う費用負担リスクについて、重要な変更がないとされた。
  13. FY2019-Q1RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative consolidated period for the first quarter. In addition, there were no material changes to the business and other risks described in the annual securities report for the preceding fiscal year.」

    特許の帰属・報酬に伴う費用負担リスクについて、重要な変更がないとされた。
  14. FY2018RestatedAnnual report

    「しかしながら、特許の帰属や報酬等については明確な判断基準はなく、判例の中には多額な報酬を認めたものがあること等から、将来的にはこれらに対して費用負担が増加する可能性も否定できません。」

    特許の帰属・報酬に関する基準の不明確さと将来の費用負担リスクが継続している。
  15. FY2018RestatedAnnual report

    「しかしながら、特許の帰属や報酬等については明確な判断基準はなく、判例の中には多額な報酬を認めたものがあること等から、将来的にはこれらに対して費用負担が増加する可能性も否定できません。」

    特許の帰属・報酬に関する基準の不明確さと将来の費用負担リスクが継続している。
  16. FY2016First statedAnnual report

    「しかしながら、特許の帰属や報酬等については明確な判断基準はなく、判例の中には多額な報酬を認めたものがあること等から、将来的にはこれらに対して費用負担が増加する可能性も否定できません。」

    共同開発・共同出願や社内発明に関する権利帰属・報酬を潜在的な費用リスクとしている。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Synclayer yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Allocation of Costs Associated with Patent Ownership and Compensation | SYNCLAYER INC. (1724) | Komori